Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis
Robert Zivadinov(Yale University), Ralph H. B. Benedict(Jacobs Institute), Jacqueline Nicholas(OhioHealth), Sarah A. Morrow(University of Calgary), Andrew L. Smith(OhioHealth), Michael G. Dwyer(Buffalo Psychiatric Center), Stephen J. Newman(Government of Western Australia), Lorena Lorefice(University of Cagliari), Dejan Jakimovski(University at Buffalo, State University of New York), Mahmoud A. AbdelRazek(Mount Auburn Hospital), Niels Bergsland(Buffalo Psychiatric Center), Tom Fuchs(Amsterdam Neuroscience), Gabriel Pardo(Oklahoma Medical Research Foundation), Menno M. Schoonheim(Amsterdam Neuroscience), Bianca Weinstock‐Guttman(ECD for the Masses (United States)), Jon Riolo(Bristol-Myers Squibb (United States)), Ina Hoti(Mount Auburn Hospital), Diego Augusto Santos Silva(Bristol-Myers Squibb (United States)), Mary Ann Picone(Holy Name Medical Center), Samuel F. Hunter(Advanced Neurosciences Institute), Myassar Zarif(Urology Associates), Mark Gudesblatt(Urology Associates)
Cited by 13
Related Papers
Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity
|PLoS ONE|2010|621
Cognition in multiple sclerosis
|Neurology|2018|533
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
|Nature Reviews Neurology|2016|413
Recommendations for cognitive screening and management in multiple sclerosis care
|Multiple Sclerosis Journal|2018|404
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment
|Neurobiology of Aging|2011|396